WAT Chart

1 Month

	Date	Diff
	2024-11-13	-0.04 %
Waters Corporation (NYSE: WAT) experienced a slight decline of 0.04% in its stock value following a 12.9% reduction in stake by Crossmark Global Holdings Inc. during the third quarter, alongside general market activity and adjustments from other institutional investors.
	2024-11-08	-0.42 %
Waters Corporation (WAT) shares fell by 0.42% despite a recent price target increase from Barclays, primarily due to a mix of analysts' ratings that include underweight and hold positions, reflecting market caution amidst varying forecasts and recent earnings that, while beating expectations, may not have been substantial enough to buoy investor sentiment. Waters Corporation (WAT) stock experienced a decline of 0.42% following mixed analyst ratings and recent trading activity by institutional investors, despite reporting better-than-expected earnings and revenue for the quarter. The stock's downturn may reflect broader market trends or investor sentiment rather than the company's financial performance directly.
	2024-11-01	+19.84 %
Waters Corporation's (WAT) stock surged by 19.84% following a consensus recommendation upgrade from analysts and positive quarterly earnings that exceeded expectations, contributing to heightened investor interest and confidence.
	2024-10-31	-1.07 %
Waters Corporation (WAT) shares fell by 1.07% amid anticipation of its upcoming quarterly earnings report, where analysts expect a decline in earnings per share compared to the previous year, reflecting potential concerns about the company's revenue trends and market performance.
	2024-10-30	+0.59 %
Waters Corporation (WAT) stock increased by 0.59% due to heightened institutional interest and investments from major firms, indicating confidence in the company's future performance despite a slight decline in quarterly revenue. Waters Corporation (WAT) stock rose by 0.59% last night, driven by increased institutional investor interest and positive analyst ratings despite a slight decline in quarterly revenues.
	2024-10-22	-1.76 %
Waters Corporation (WAT) stock fell by 1.76% due to a significant reduction in holdings by Exchange Traded Concepts LLC and mixed ratings from various brokerages, reflecting uncertainty among institutional investors about the company's future performance.
	2024-10-16	-1.67 %
Waters Corporation (NYSE: WAT) stock decreased by 1.67% following mixed signals from recent stock ratings and a slight decline in quarterly revenue compared to the previous year, indicating potential market concerns.
	2024-09-17	+0.1 %
Waters Corporation (WAT) stock rose 0.1% likely due to positive developments in the investigational drug DNL343, which shows promise in inhibiting the integrated stress response and reducing neurodegeneration in mouse models, indicating potential for future therapeutic applications.
	2024-08-01	+4.83 %
Waters Corporation's (WAT) stock rose 4.83% following TD Cowen's upgrade of its price target from $325 to $363, driven by positive comments about pharmaceutical spending and potential recovery in the China market after the company's second-quarter earnings call, despite a conservative outlook for 2024.
	2024-07-31	+2.63 %
Waters Corporation (WAT) stock rose by 2.63% due to overall positive market sentiment and the strong performance of several companies, indicating optimistic investor confidence. Waters Corporation (WAT) stock increased by 2.63% due to positive market sentiment alongside favorable earnings reports and news about corporate performances that likely boosted investor confidence across the sector.
	2024-06-03	+0.32 %
The article is about Waters Corporation unveiling the Xevo MRT, a highly advanced mass spectrometer, designed to deliver high resolution and speed for large population studies and epidemiology-type research, which has led to the Waters Corporation stock (WAT) going up by 0.32% last night due to the innovative technology and features of the new Xevo MRT system.
	2024-05-29	-1.26 %
The article discusses how Waters Corporation (WAT) stock was down by 1.26% yesterday, attributed to concerns over the company's financial performance and market conditions.